Apatinib Treatment as the Neoadjuvant Therapy in Advanced Colorectal Cancer
Status:
Unknown status
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
Apatinib has been proved to be effective and safe among patients in advanced colorectal
cancer in several trials. the investigators aimed to evaluate its efficacy and safety as the
neoadjuvant therapy in real world practice, and to explore factors associated with efficacy.